A teenage girl who underwent a kidney transplant after experiencing kidney failure associated with ANCA-associated vasculitis (AAV) is among…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A new study from Japan found that people with ANCA-associated vasculitis (AAV) have significantly higher levels of a protein…
Free-floating CD95L, a protein involved in inflammation and immune responses, is found at significantly higher levels in the blood of…
May is Vasculitis Awareness Month, and advocates are gearing up to raise awareness, foster connection within the community, and raise…
Following allegations of manipulated data in its regulatory application, a division of the U.S. Food and Drug Administration (FDA) has…
In most people with kidney damage due to ANCA-associated vasculitis (AAV), outcomes from initial treatment to bring the disease…
ANCA-associated vasculitis (AAV) patients with antibodies targeting the myeloperoxidase (MPO) protein have higher levels of immune-activating pieces of the…
People with active granulomatosis with polyangiitis (GPA), the most common type of ANCA-associated vasculitis (AAV), had significantly higher levels…
Amgen said it declined a U.S. Food and Drug Administration (FDA) request to voluntarily withdraw Tavneos (avacopan), an…
Following questions about the integrity of clinical trial data, regulators in Europe are taking a second look at Tavneos…